(Nasdaq: PRPH) Profile
OUR NEW PROFILE IS: (NASDAQ: PRPH) 2022 REVENUES TOTALED $122 MILLION AS OF DEC. 31, CASH AND EQUIVALENTS TOTALED $17.4 MILLION WITH WORKING CAPITAL OF $44.8 MILLION PRPH WILL RELEASE FIRST QUARTER FINANCIAL RESULTS ON THURSDAY PROPHASE LABS CEO TED KARKUS NAMED ONE OF INC MAGAZINE’S 10 MOST INNOVATIVE HEALTHCARE LEADERS TO WATCH IN 2023 […]
(Nasdaq: TRNR) Profile
OUR NEW PROFILE IS: (NASDAQ: TRNR) ___________________________________ (TRNR) INTERACTIVE STRENGTH INC. D/B/A FORME ANNOUNCES CLOSING OF $12 MILLION INITIAL PUBLIC OFFERING HOME FITNESS MARKET WAS 11.3BILL IN 2021 & WILL ATTAIN USD 17.3 BILLION BY 2030 GROWING AT 4.9% CAGR – ACUMEN RESEARCH AND CONSULTING CHECK OUT THE INVESTOR PRESENTATION HERE_ _______________________________ ______________________________ Hello Everyone, We have a […]
(Nasdaq: NMTC) Profile
OUR NEW PROFILE IS: (NASDAQ: NMTC) STRATEGIC PARTNERSHIP WITH ZIMMER BIOMET (NYSE:ZBH, ~$27B MKT CAP) TO EXCLUSIVELY COMMERCIALIZE AND DISTRIBUTE EVO® DIAGNOSTIC ELECTRODES; ACCELERATED PAYMENT OF $3.5 MILLION RECEIVED IN AUGUST 2022 NEURONE® RECEIVES FDA 510(K) CLEARANCE TO MARKET ITS EVO® SEEG SYSTEM FOR LESS THAN 30 DAY USE NEUROONE® SUCCESSFULLY COMPLETES INITIAL ANIMAL IMPLANT […]
BRAND NEW NASDAQ: VUZI ON WATCH!
OUR NEW PROFILE IS: (NASDAQ: VUZI) __________ VUZIX IS A PIONEER IN WEARABLE COMPUTING, AUGMENTED REALITY, OPTICS AND DISPLAY ENGINES AND HAS BEEN DELIVERING SOLUTIONS TO CUSTOMERS FOR OVER 20 YEARS VUZI IS SITTING WITH JUST OVER $73 MILLION IN CASH AS OF DECEMBER 31 VUZIX ACHIEVES RECORD SMART GLASSES SALES IN Q1 2023 FOR […]
CTXR BRAND NEW PROFILE!
OUR NEW PROFILE IS: NASDAQ: CTXR “MINO-WRAP” COULD REVOLUTIONIZE $400 MILLION POST-MASTECTOMY INFECTION PREVENTION MARKET $41.7 MILLION IN CASH AND CASH EQUIVALENTS AS OF SEPTEMBER 30, 2022 MINO-LOK® PHASE 3 TRIAL CLOSER TO COMPLETION WITH 169 PATIENTS RECRUITED, 72 FAILURE EVENTS AND 17 PATIENTS IN ACTIVE TREATMENT OR PENDING DATA REVIEW DOWNLOAD THE INVESTOR […]
(NASDAQ: GNPX) Brand NEW Profile
OUR NEW PROFILE IS: (NASDAQ: GNPX) ________________________ GNPX HAS ALREADY RECEIVED FAST TRACK DESIGNATION FOR ACCLAIM 2 GENPREX ANNOUNCES U.S. PATENT FOR REQORSA™ IMMUNOGENE THERAPY IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS TO TREAT CANCERS INDEPENDENT RESEARCHERS FIND THAT TUSC2, THE GENE DELIVERED BY GENPREX’S REQORSA®, FUNCTIONS AS A NOVEL TUMOR SUPPRESSOR FOR GLIOBLASTOMA GENPREX […]
(Nasdaq: BTCY) Profile
OUR NEW PROFILE IS: (NASDAQ: BTCY) ___________________________________ Revenue is up 27.4% YOY Residual revenues are driven by a 95% retention rate Biotricity surpasses $10 million in annual revenue run rate Bioheart named to TIME’s list of The Best Inventions of 2022′ Biotricity surpasses 2 billion recorded and analyzed heartbeats for atrial […]
OUR NEW PROFILE IS: (NASDAQ: KSPN)
OUR NEW PROFILE IS: (NASDAQ: KSPN) 150 Employees, Serving 5,000 Brands in 20 Countries The Entire Float is Under 4Million According to Yahoo Finance Yahoo Also Has Revenues Over $130 Million for 2022 ______________ Hello Everyone, We have another low float profile for todays session. Pull up KSPN Immediately and start your research. […]
BSGM Nasdaq Profile On Watch!
_______ OUR NEW PROFILE IS: (NASDAQ: BSGM) BIOSIG SEES POSITIVE MOMENTUM FROM SALES PIPELINE GROWTH OVER 3,000 PROCEDURES HAVE BEEN PERFORMED USING THE PURE EP™ SYSTEM WITH MORE THAN 80 PHYSICIANS AT 21 HOSPITALS ACROSS THE UNITED STATES SUBSTANTIAL AND GROWING IP PATENT PORTFOLIO IN 2022 THE CEO PURCHASED OVER 200K SHARES THE LAST TIME […]
NEW PROFILE (Nasdaq: LSDI)
OUR NEW PROFILE IS: (NASDAQ: LSDI) LUCY SCIENTIFIC DISCOVERY ANNOUNCES FIRST COMMERCIAL SALE OF PSILOCYBIN FOLLOWING INITIAL DELIVERY OF DMT AND 5-MEO-DMT TO HADASSAH BRAINLABS LUCY SCIENTIFIC TEAMS UP WITH PRAMANTHA GROUP TO SECURE KEY GOVERNMENT CONTRACTS AND GRANTS TO ENHANCE ITS MANUFACTURING CAPABILITIES IN EARLY FEBRUARY THE COMPANY CLOSED A $7.5MILL IPO *****HUGE BREAKING […]